News And Events

Congratulations Dr. Armstrong! Congratulations to Dr. Melissa Armstrong on the publication of “Externally‐Led Patient‐Focused Drug Development Meeting (EL‐PFDD) for Dementia with Lewy Bodies—DLB: Voices of Lived Experience on Life with Lewy and Unmet Treatment Needs,” which appears in the December issue of Alzheimer’s and Dementia. Abstract Background Dementia with Lewy…

Congratulations on your new publication! Congratulations to Drs. Melissa Armstrong and Abbas Babajani-Feremi on the publication of “Synergistic Neurodegeneration in Alzheimer’s Disease with Lewy Body Co‐Pathology: Insights from Deep Learning and CSF α‐Synuclein Seed Amplification Assays,” which appears in the December issue of Alzheimer’s and Dementia Abstract Background Alzheimer’s disease…

Congratulations Dr. Melissa Armstrong! Congratulations to Dr. Melissa Armstrong on the publication of “White matter hyperintensities among Hispanic and non‐Hispanic Whites: the relevance of demographic, biological and non‐biological variables,” which appears in the December issue of Alzheimer’s and Dementia. Abstract Background The severity of white matter hyperintensities (WMHs) is known…

Congratulations to Dr. Nicholas McFarland! Dr. McFarland Recently published the article “Cutaneous Phosphorylated Alpha‐Synuclein in Lewy Body Dementia,” in the December 2025 issues of the Annals of Clinical and Translational Neurology. ABSTRACT Objective To determine the test performance of cutaneous phosphorylated alpha-synuclein (P-SYN) in dementia with Lewy bodies (DLB), individuals…

Faculty Sound Bite… “It becomes obvious, just absolutely obvious, when you see the folks with disease that this isn’t just a disease of dopamine; it isn’t just a disease of the brain. We see it in the gut. We see it in the skin. We see it in multiple organs.

Faculty Sound bite… “DBS used to be seen as a last resort, but we now know it provides the most sustained benefit when offered in the moderate stages of Parkinson’s disease, when motor complications are the main source of disability. We know this therapy is effective and safe. The challenge…

Congratulations to Dr. Barlas Benkli! Please join us in celebrating Dr. Barlas Benkli on his acceptance into the Emerging Leadership Program with the American Headache Society (AHS). This prestigious opportunity recognizes his dedication to advancing the field of headache medicine and his commitment to leadership within the specialty. As part…

Congratulations to Dr. Michael Okun! Please join us in congratulating Dr. Michael Okun on his recent publication in the New England Journal of Medicine titled “Should We Treat Midlife Vascular Risk Factors to Prevent Parkinson’s Disease?” This important piece highlights a critical question in the field of neurology—whether addressing vascular…

Congratulations Dr. DeKosy Congratulations to Dr. Steven DeKosky on the publication of “Continuous Glucose Monitoring in Insulin-Treated Older Adults With Diabetes and Alzheimer Disease and Related Dementias,” which appears in the December 2nd issue of JAMA. Abstract Importance: Cognitive impairment and glycemic control have a bidirectional association. Understanding the impact of…

Congratulations to Dr. Tejas Mehta and Joshua Wong on the publication of “The Role of Artificial Intelligence in Deep Brain Stimulation,” which appears in the November issue of Seminars in Neurology.